Page last updated: 2024-10-30

mesalamine and Myocardial Infarction

mesalamine has been researched along with Myocardial Infarction in 3 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Künzel, SR1
Winter, L1
Hoffmann, M1
Kant, TA1
Thiel, J1
Kronstein-Wiedemann, R1
Klapproth, E1
Lorenz, K1
El-Armouche, A1
Kämmerer, S1
Kounis, GN1
Kouni, SA1
Hahalis, G1
Kounis, NG1
Schölmerich, J1

Other Studies

3 other studies available for mesalamine and Myocardial Infarction

ArticleYear
Investigation of mesalazine as an antifibrotic drug following myocardial infarction in male mice.
    Physiological reports, 2023, Volume: 11, Issue:17

    Topics: Animals; Heart; Male; Mesalamine; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium

2023
Mesalamine hypersensitivity and Kounis syndrome in a pediatric ulcerative colitis patient.
    World journal of gastroenterology, 2008, Dec-14, Volume: 14, Issue:46

    Topics: Angina, Unstable; Anti-Inflammatory Agents, Non-Steroidal; Child; Colitis, Ulcerative; Drug Hypersen

2008
[5-aminosalicylic acid and thrombocyte function].
    Deutsche medizinische Wochenschrift (1946), 1995, May-19, Volume: 120, Issue:20

    Topics: Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Humans; Mesalamine; Myocardi

1995